E LEE BENDEKGEY Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for E LEE BENDEKGEY.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of E LEE BENDEKGEY. E LEE BENDEKGEY is a Sr. VP CFO and General Counsel in ARCA biopharma, Inc. ($ABIO).
Address: 201 INDUSTRIAL ROAD SUITE 310 SAN CARLOS 94070 CA
Companies in which E LEE BENDEKGEY is an Insider
ARCA biopharma, Inc.
Industry: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835]
Position of E LEE BENDEKGEY: Sr. VP CFO and General Counsel
Holdings: 6,511 shares
Current Value: $16,929
Latest Transaction: Feb 04 2008
$ABIO Market Capitalization: $23.40M
$ABIO Previous Close: $2.60
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Latest Insider Trading Transactions of E LEE BENDEKGEY
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb 04 2008 | ABIO | ARCA biopharma, In ... | BENDEKGEY E LEE | Sr. VP CFO and Gene ... | Option Exercise | A | 1.57 | 29,168 | 45,648 | 29,168 | |
| Feb 04 2008 | ABIO | ARCA biopharma, In ... | BENDEKGEY E LEE | Sr. VP CFO and Gene ... | Option Exercise | A | 1.57 | 70,832 | 110,852 | 70,832 | |
| Feb 04 2008 | ABIO | ARCA biopharma, In ... | BENDEKGEY E LEE | Sr. VP CFO and Gene ... | Buy | I | 1.48 | 1,932 | 2,857 | 6,511 | 4.6 K to 6.5 K (+42.19 %) |
| Feb 04 2008 | ABIO | ARCA biopharma, In ... | BENDEKGEY E LEE | Sr. VP CFO and Gene ... | Buy | I | 1.85 | 1,445 | 2,678 | 4,579 | 3.1 K to 4.6 K (+46.11 %) |
| Feb 04 2008 | ABIO | ARCA biopharma, In ... | BENDEKGEY E LEE | Sr. VP CFO and Gene ... | Buy | I | 2.90 | 924 | 2,678 | 3,134 | 2.2 K to 3.1 K (+41.81 %) |
| Feb 04 2008 | ABIO | ARCA biopharma, In ... | BENDEKGEY E LEE | Sr. VP CFO and Gene ... | Buy | I | 2.79 | 962 | 2,682 | 2,210 | 1.2 K to 2.2 K (+77.08 %) |